Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development. It offers a crowdsourced platform that helps people to access, understand, and benefit from the human genome; access direct-to-consumer genetic testing; and give consumers personalized information about their genetic health risks, ancestry, and traits. The company was incorporated in 2006 and is based in Sunnyvale, California with an additional office in Mountain View, California.
Website: 23andme.com



Growth: Bad revenue growth rate -12.0%, there is slowdown compared to average historical growth rates 25.6%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of +5.2%

Profitability: LTM EBITDA margin is negative, -22.8%. On average the margin is improving steadily. Gross margin is high, +50.8%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 80% of quarters (showing a gain of +$0.03 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -40.9% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 124.5% higher than minimum and 88.6% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 1.1x by EV / Sales multiple , the company can be 10.5% overvalued

Key Financials (Download financials)

Ticker: ME
Share price, USD:  (0.0%)0.6063
year average price 0.7496  


year start price 2.5500 2025-02-15

max close price 2.8000 2025-02-18

min close price 0.5305 2025-03-26

current price 0.6063 2026-02-14
Common stocks: 495 892 915

Dividend Yield:  0.0%
EV / Sales: 1.3x
Margin (EBITDA LTM / Revenue): -22.8%
Fundamental value created in LTM:
Market Cap ($m): 301
Net Debt ($m): -55
EV (Enterprise Value): 246
Price to Book: 9.2x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-04-01techxplore.com

US regulators tell 23andMe to protect genetic data

2025-03-29marketwatch.com

23andMe's failure shows how risky it can be to invest in a SPAC

2025-03-28youtube.com

Here's how to delete your genetic data from 23andMe

2025-03-27proactiveinvestors.com

23andMe shares jump as US judge allows sale of customer data

2025-03-27techxplore.com

23andMe filed for bankruptcy. Here's why you should be worried about your privacy

2025-03-26businessinsider.com

23andMe cofounder says company 'lost its way' without 'proper governance'

2025-03-26cnbc.com

23andMe co-founder lashes out at CEO Wojcicki after bankruptcy filing, says board lacked oversight

2025-03-26youtube.com

We don't know who could buy 23andMe data and how it could be used against us, says Theresa Payton

2025-03-25cnbc.com

With 23andMe entering bankruptcy, here's how to delete your genetic data

2025-03-25foxbusiness.com

23andMe bankruptcy: Will your private data be protected?
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-03-31 2021-03-31
symbol ME ME ME ME ME ME ME ME ME ME ME ME ME
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-08-04 2024-11-12 2024-08-08 2024-02-07 2023-11-08 2023-08-08 2023-02-08 2022-11-07
acceptedDate 2025-08-04 16:25:13 2025-06-11 16:53:48 2024-11-12 07:41:07 2024-08-08 16:11:14 2024-05-30 16:06:42 2024-02-07 16:07:48 2023-11-08 16:15:52 2023-08-08 16:16:19 2023-05-25 16:14:04 2023-02-08 16:11:59 2022-11-07 16:12:03 2022-05-27 16:03:56 2021-03-31 00:00:00
calendarYear 2025 2024 2024 2023 2023 2023 2023 2023
period Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
revenue 25M 190M 44M 40M 220M 45M 50M 61M 299M 67M 76M 272M 244M
costOfRevenue 12M 90M 22M 26M 120M 25M 28M 30M 165M 36M 37M 139M 127M
grossProfit 14M 100M 22M 15M 99M 20M 22M 31M 134M 31M 38M 133M 117M
grossProfitRatio 0.532 0.508 0.364 0.446 0.435 0.504 0.459 0.506
researchAndDevelopmentExpenses 14M 102M 41M 43M 205M 42M 55M 62M 223M 57M 53M 189M 160M
generalAndAdministrativeExpenses 23M 132M 23M 38M 150M 36M 30M 55M 116M 31M 34M 97M 99M
sellingAndMarketingExpenses 6M 40M 10M 9M 59M 22M 11M 15M 120M 40M 16M 100M 43M
sellingGeneralAndAdministrativeExpenses 30M 172M 39M 47M 209M 57M 41M 71M 236M 71M 50M 198M 142M
otherExpenses 0 67M 4M 0 7M 23 000 145 000 333 000 0 855 000 3M 0 0
operatingExpenses 44M 341M 84M 87M 421M 101M 98M 136M 459M 128M 106M 387M 302M
costAndExpenses 56M 431M 105M 112M 541M 126M 126M 166M 624M 164M 144M 526M 429M
interestIncome 86 000 7M 2M 3M 14M 3M 4M 4M 10M 4M 1M 277 000 255 000
interestExpense 0 0 0 0 0 0 0 0 0 1M 1M 0 0
depreciationAndAmortization 4M 23M 7M 6M 29M 7M 8M 8M 36M 9M 9M 26M 20M
ebitda -27M -156M -52M -66M -292M 127M -66M -93M -278M -97M -59M -228M -165M
ebitdaratio -1.048 -1.184 -1.574 2.831 -1.314 -1.523 -1.451 -0.775
operatingIncome -31M -241M -61M -72M -321M -281M -79M -109M -324M -97M -68M -254M -185M
operatingIncomeRatio -1.208 -1.388 -1.78 -6.284 -1.583 -1.795 -1.451 -0.899
totalOtherIncomeExpensesNet 74 000 5M 2M 3M -345M -200M -3M -4M 10M 5M 705 000 33M 2M
incomeBeforeTax -31M -235M -59M -69M -667M -278M -75M -105M -314M -93M -67M -221M -184M
incomeBeforeTaxRatio -1.205 -1.342 -1.717 -6.212 -1.505 -1.719 -1.383 -0.89
incomeTaxExpense -7M -41 000 -41 000 0 73 000 19 000 36 000 -90 000 -3M -613 000 -1M -3M 0
netIncome -24M -281M -59M -69M -667M -278M -75M -105M -312M -92M -66M -217M -183M
netIncomeRatio -0.937 -1.341 -1.717 -6.212 -1.505 -1.719 -1.374 -0.873
eps -0.87 -10.88 -2.32 -2.799 -27.59 -0.58 -0.16 -0.23 -13.81 -0.2 -0.15 -9.96 -9.02
epsdiluted -0.87 -2.32 -2.799 -0.58 -0.16 -0.23 -0.2 -0.15
weightedAverageShsOut 27M 26M 26M 25M 24M 481M 475M 462M 23M 453M 450M 22M 20M
weightedAverageShsOutDil 27M 26M 26M 25M 24M 481M 475M 462M 23M 453M 450M 22M 20M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-06-11 2024-05-30 2023-05-25 2022-05-27 2021-03-31
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 7M 14M 10M 277 000 255 000
ebit -179M -321M -314M -254M -185M
nonOperatingIncomeExcludingInterest -61M 0 -10M 0 0
netIncomeFromContinuingOperations -235M -667M -312M -217M -184M
netIncomeFromDiscontinuedOperations -46M 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -281M -667M -312M -217M -184M
epsDiluted -10.88 -28.01 -13.8 -9.96 -9.02

Balance Sheet Statement

Property 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-03-31 2021-03-31
symbol ME ME ME ME ME ME ME ME ME ME ME ME ME
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-08-04 2024-11-12 2024-08-08 2024-02-07 2023-11-08 2023-08-08 2023-02-08 2022-11-07
acceptedDate 2025-08-04 16:25:13 2025-06-11 16:53:48 2024-11-12 07:41:07 2024-08-08 16:11:14 2024-05-30 16:06:42 2024-02-07 16:07:48 2023-11-08 16:15:52 2023-08-08 16:16:19 2023-05-25 16:14:04 2023-02-08 16:11:59 2022-11-07 16:12:03 2022-05-27 16:03:56 2021-03-31 00:00:00
calendarYear 2025 2024 2024 2023 2023 2023 2023 2023
period Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
cashAndCashEquivalents 40M 38M 127M 171M 218M 242M 256M 314M 387M 433M 411M 553M 282M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 40M 38M 127M 171M 218M 242M 256M 314M 387M 433M 411M 553M 282M
netReceivables 1M 21M 25M 28M 9M 24M 2M 4M 2M 27M 53M 3M 2M
inventory 13M 16M 15M 15M 12M 16M 15M 12M 10M 12M 14M 11M 6M
otherCurrentAssets 36M 16M 23M 14M 2M 3M 18M 21M 13M 21M 29M 9M 7M
totalCurrentAssets 90M 103M 189M 228M 251M 310M 298M 360M 425M 509M 506M 602M 314M
propertyPlantEquipmentNet 1M 2M 70M 74M 77M 81M 85M 90M 95M 91M 96M 105M 124M
goodwill 0 0 0 0 0 153M 352M 352M 352M 352M 352M 352M 0
intangibleAssets 23M 45M 29M 51M 54M 55M 57M 60M 61M 63M 76M 84M 7M
goodwillAndIntangibleAssets 23M 45M 29M 51M 54M 208M 409M 411M 413M 415M 428M 435M 7M
longTermInvestments 0 0 0 9M 7M 7M 7M 0 7M 0 0 7M 56M
taxAssets 0 0 0 0 0 -7M -7M 0 -7M 0 0 -7M -56M
otherNonCurrentAssets 30M 11M 31M 6M 7M 9M 9M 10M 10M 10M 10M 10M 8M
totalNonCurrentAssets 54M 57M 130M 140M 145M 298M 503M 511M 518M 516M 535M 550M 139M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 144M 160M 319M 368M 395M 608M 801M 871M 943M 1 025M 1 041M 1 152M 452M
accountPayables 14M 6M 6M 11M 12M 13M 9M 13M 13M 14M 11M 38M 12M
shortTermDebt 29M 0 9M 18M 0 8M 8M 8M 0 8M 8M 8M 6M
taxPayables 0 433 000 1M 1M 1M 1M 873 000 1M 1M 2M 1M 2M 335 000
deferredRevenue 41M 49M 70M 68M 65M 80M 40M 48M 63M 109M 82M 63M 71M
otherCurrentLiabilities 28M 10M 66M 55M 22M 42M 45M 50M 53M 69M 44M 28M 14M
totalCurrentLiabilities 111M 124M 153M 153M 127M 144M 102M 119M 149M 200M 145M 153M 122M
longTermDebt 16M 0 62M 65M 0 70M 73M 75M 0 71M 74M 0 0
deferredRevenueNonCurrent 0 0 0 5M 10M 15M 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 224 000 2M 2M 2M 1M 1M 1M 1M 1M 2M -24M 5M 1M
totalNonCurrentLiabilities 347 000 63M 64M 72M 79M 87M 74M 77M 79M 74M 77M 83M 926M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 18M 68M 72M 74M 77M 79M 81M 83M 85M 80M 82M 86M 94M
totalLiabilities 112M 187M 217M 225M 207M 231M 176M 196M 229M 274M 221M 236M 1 048M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 837M
commonStock 3000 3000 3000 51 000 49 000 48 000 48 000 47 000 46 000 45 000 45 000 45 000 12 000
retainedEarnings -2 478M -2 454M -2 302M -2 242M -2 173M -1 964M -1 686M -1 611M -1 506M -1 442M -1 350M -1 195M -977M
accumulatedOtherComprehensiveIncomeLoss 0 0 0 0 0 0 -0 -954 000 -620 000 -311 000 2M 179 000 0
othertotalStockholdersEquity 2 435M 2 404M 2 386M 2 341M 2 311M 2 287M 2 194M 2 168M
totalStockholdersEquity 33M -27M 102M 144M 189M 377M 625M 675M 714M 751M 819M 916M 242M
totalEquity 33M -27M 102M 144M 189M 377M 625M 675M 714M 751M 819M 916M -596M
totalLiabilitiesAndStockholdersEquity 144M 319M 368M 608M 801M 871M 1 025M 1 041M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 144M 160M 319M 368M 395M 608M 801M 871M 943M 1 025M 1 041M 1 152M 452M
totalInvestments 0 0 0 9M 7M 7M 7M 0 7M 0 0 7M 56M
totalDebt 27M 68M 72M 74M 77M 79M 81M 83M 85M 80M 82M 86M 94M
netDebt -13M 30M -55M -96M -141M -164M -175M -231M -302M -353M -329M -467M -189M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-06-11 2024-05-30 2023-05-25 2022-05-27 2021-03-31
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 1M 3M 2M 3M 2M
otherReceivables 20M 6M 0 0 0
prepaids 12M 9M 13M 25M 15M
totalPayables 17M 13M 14M 40M 13M
otherPayables 11M 1M 1M 2M 335 000
accruedExpenses 41M 19M 12M 7M 12M
capitalLeaseObligationsCurrent 7M 9M 8M 8M 6M
capitalLeaseObligationsNonCurrent 61M 68M 78M 79M 88M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 2 427M 2 362M 2 221M 2 110M 382M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-03-31 2021-03-31
symbol ME ME ME ME ME ME ME ME ME ME ME ME ME
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-08-04 2024-11-12 2024-08-08 2024-02-07 2023-11-08 2023-08-08 2023-02-08 2022-11-07
acceptedDate 2025-08-04 16:25:13 2025-06-11 16:53:48 2024-11-12 07:41:07 2024-08-08 16:11:14 2024-05-30 16:06:42 2024-02-07 16:07:48 2023-11-08 16:15:52 2023-08-08 16:16:19 2023-05-25 16:14:04 2023-02-08 16:11:59 2022-11-07 16:12:03 2022-05-27 16:03:56 2021-03-31 00:00:00
calendarYear 2025 2024 2024 2023 2023 2023 2023 2023
period Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome -24M -281M -39M -69M -667M -278M -75M -105M -312M -92M -66M -217M -184M
depreciationAndAmortization 2M 23M 370 000 6M 29M 7M 8M 8M 36M 9M 9M 26M 20M
deferredIncomeTax 0 0 0 0 0 19 000 36 000 23M 0 -4M -1M 0 57 000
stockBasedCompensation 6M 62M 24M 22M 120M 26M 24M 51M 116M 34M 29M 58M 88M
changeInWorkingCapital -8M -36M -43M -1M -547 000 33M -15M -24M -16M 64M -45M -515 000 2M
accountsReceivables 126 000 2M -270 000 2M -1M -17M 3M -2M 1M 26M -50M -899 000 4M
inventory 2M -3M -3M -2M -2M -687 000 -3M -2M 542 000 2M -2M -4M 8M
accountsPayables 6M -6M -5M -309 000 -996 000 5M -4M -2000 -25M 4M -8M 23M 137 000
otherWorkingCapital -16M -29M -35M -823 000 4M 46M -11M -20M 6M 32M 15M -18M -10M
otherNonCashItems -5M 61M -1M -44 000 353M 199M 1M -23M 10M 14M 1M -33M -876 000
netCashProvidedByOperatingActivities -29M -170M -60M -43M -164M -12M -57M -69M -165M 26M -73M -167M -74M
investmentsInPropertyPlantAndEquipment -42 000 -869 000 1M -366 000 -1M -2M -3M -3M -4M -3M -2M -14M -7M
acquisitionsNet 0 0 0 148 000 30 000 1000 0 0 5000 0 0 -94M 838 000
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites -991 000 -4M -938 000 -2M -2M 5000 -2000 2000
netCashUsedForInvestingActivites -1M -3M -1M -2M -3M -3M -3M -2M
debtRepayment 25M 0 0 0 0 0 0 0
commonStockIssued 0 0 57 000 121 000 2M 0 0 0
commonStockRepurchased 0 0 331 000 0 3M -16 000 -21 000 0 -197 000 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0
otherFinancingActivites -717 000 260 000 9000 -16 000 -21 000 -114 000 -11 000 6M
netCashUsedProvidedByFinancingActivities 24M 260 000 9000 105 000 2M -114 000 -11 000 6M
effectOfForexChangesOnCash 0 0 0 0 0 0 334 000 -334 000 385 000 -758 000 829 000 -146 000 0
netChangeInCash -6M -174M -43M -44M -170M -14M -58M -72M -167M 22M -69M 271M 75M
cashAtEndOfPeriod 46M 51M 137M 171M 218M 251M 265M 323M 395M 441M 419M 562M 291M
cashAtBeginningOfPeriod 51M 225M 180M 218M 388M 265M 323M 395M 562M 419M 488M 291M 216M
operatingCashFlow -29M -170M -60M -43M -164M -12M -57M -69M -165M 26M -73M -167M -74M
capitalExpenditure -42 000 -7M 1M -1M -10M -2M -3M -3M -11M -3M -2M -14M -7M
freeCashFlow -29M -176M -59M -45M -174M -14M -60M -72M -177M 22M -75M -181M -82M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-06-11 2024-05-30 2023-05-25 2022-05-27 2021-03-31
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -3M -9M -7M 1000 0
netCashProvidedByInvestingActivities -4M -10M -11M -108M -7M
netDebtIssuance -800 000 0 0 0 0
longTermNetDebtIssuance -800 000 0 0 0 0
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 0 4M 11M 310M 83M
netCommonStockIssuance 0 0 0 310M 0
commonStockIssuance 0 4M 11M 310M 158M
netPreferredStockIssuance 0 0 0 0 83M
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 521 000 -230 000 -890 000 236M 73M
netCashProvidedByFinancingActivities -279 000 4M 10M 546M 155M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 0 0 0

Earning call transcript

2025 q3
2024-11-12 ET (fiscal 2025 q2)
2025 q2
2024-08-09 ET (fiscal 2025 q1)
2025 q1
2024-05-23 ET (fiscal 2024 q4)
2024 q4
2024-02-07 ET (fiscal 2024 q3)
2024 q3
2023-11-08 ET (fiscal 2024 q2)
2024 q1
2023-05-25 ET (fiscal 2023 q4)
2023 q4
2023-02-08 ET (fiscal 2023 q3)
2023 q3
2022-11-07 ET (fiscal 2023 q2)
2023 q2
2022-08-08 ET (fiscal 2023 q1)
2023 q1
2022-05-26 ET (fiscal 2022 q4)
2022 q4
2022-02-10 ET (fiscal 2022 q3)
2022 q2
2021-08-13 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-12-04 21:02 ET
23andMe published news for 2025 q3
SEC form 8
2025-12-04 21:02 ET
23andMe published news for 2025 q3
SEC form 8
2025-11-17 16:31 ET
23andMe published news for 2025 q3
SEC form 8
2025-11-17 16:31 ET
23andMe published news for 2025 q3
SEC form 8
2025-11-04 14:59 ET
23andMe published news for 2025 q3
SEC form 8
2025-11-04 14:59 ET
23andMe published news for 2025 q3
SEC form 8
2025-10-06 20:30 ET
23andMe published news for 2025 q3
SEC form 8
2025-10-06 20:30 ET
23andMe published news for 2025 q3
SEC form 8
2025-10-01 20:31 ET
23andMe published news for 2025 q3
SEC form 8
2025-10-01 20:31 ET
23andMe published news for 2025 q3
SEC form 8
2025-10-01 20:31 ET
23andMe published news for 2025 q3
SEC form 8
2025-10-01 20:31 ET
23andMe published news for 2025 q3
SEC form 8
2025-10-01 20:31 ET
23andMe published news for 2025 q3
SEC form 8
2025-09-22 20:14 ET
23andMe published news for 2025 q2
SEC form 8
2025-09-22 20:14 ET
23andMe published news for 2025 q2
SEC form 8
2025-09-22 20:14 ET
23andMe published news for 2025 q2
SEC form 8
2025-09-22 20:14 ET
23andMe published news for 2025 q2
SEC form 8
2025-09-22 20:14 ET
23andMe published news for 2025 q2
SEC form 8
2025-09-22 20:14 ET
23andMe published news for 2025 q2
SEC form 8
2025-08-18 11:00 ET
23andMe published news for 2025 q2
SEC form 8
2025-08-18 11:00 ET
23andMe published news for 2025 q2
SEC form 8
2025-08-18 11:00 ET
23andMe published news for 2025 q2
SEC form 8
2025-08-15 20:05 ET
23andMe published news for 2025 q2
SEC form 8
2025-08-15 20:05 ET
23andMe published news for 2025 q2
SEC form 10
2025-08-04 20:25 ET
23andMe published news for 2025 q2
SEC form 8
2025-06-30 12:13 ET
23andMe published news for 2025 q1
SEC form 8
2025-06-30 12:13 ET
23andMe published news for 2025 q1
SEC form 10
2025-06-11 20:53 ET
23andMe published news for 2025 q1
SEC form 8
2025-05-19 11:31 ET
23andMe published news for 2025 q1
SEC form 8
2025-05-19 11:31 ET
23andMe published news for 2025 q1
SEC form 8
2025-05-02 20:15 ET
23andMe published news for 2025 q1
SEC form 8
2025-05-02 20:15 ET
23andMe published news for 2025 q1
SEC form 10
2025-02-06 21:27 ET
23andMe reported for 2024 q4
SEC form 10
2025-02-06 00:00 ET
23andMe reported for 2024 q4
SEC form 8
2025-01-28 00:00 ET
23andMe published news for 2024 q4
SEC form 8
2025-01-28 00:00 ET
23andMe reported for 2024 q4
SEC form 10
2024-11-12 07:41 ET
23andMe reported for 2024 q3
SEC form 8
2024-11-12 07:35 ET
23andMe published news for 2024 q3
SEC form 8
2024-11-12 07:35 ET
23andMe reported for 2024 q3
SEC form 10
2024-11-12 00:00 ET
23andMe reported for 2024 q3
SEC form 10
2024-08-08 16:11 ET
23andMe published news for 2024 q2
SEC form 8
2024-08-08 16:06 ET
23andMe published news for 2024 q2
SEC form 8
2024-08-08 16:06 ET
23andMe reported for 2024 q2
SEC form 10
2024-08-08 00:00 ET
23andMe published news for 2024 q2
SEC form 10
2024-05-30 00:00 ET
23andMe published news for 2024 q1
SEC form 8
2024-05-23 16:07 ET
23andMe published news for 2024 q1
SEC form 8
2024-05-23 16:07 ET
23andMe reported for 2024 q1
SEC form 10
2024-02-07 00:00 ET
23andMe reported for 2023 q4
SEC form 8
2024-02-07 00:00 ET
23andMe published news for 2023 q4
SEC form 8
2024-02-07 00:00 ET
23andMe reported for 2023 q4
SEC form 8
2023-11-08 16:29 ET
23andMe reported for 2023 q3
SEC form 10
2023-11-08 16:15 ET
23andMe reported for 2023 q3
SEC form 10
2023-11-08 00:00 ET
23andMe reported for 2023 q3
SEC form 10
2023-08-08 16:16 ET
23andMe reported for 2023 q2
SEC form 6
2023-08-08 16:10 ET
23andMe reported for 2023 q2
SEC form 10
2023-08-08 00:00 ET
23andMe reported for 2023 q2
SEC form 8
2023-08-08 00:00 ET
23andMe reported for 2023 q2
SEC form 6
2023-07-26 16:05 ET
23andMe published news for 2023 q2
SEC form 6
2023-06-09 16:05 ET
23andMe published news for 2023 q1
SEC form 10
2023-05-25 16:14 ET
23andMe reported for 2023 q1
SEC form 6
2023-05-25 16:08 ET
23andMe reported for 2023 q1
SEC form 10
2023-05-25 00:00 ET
23andMe reported for 2023 q1
SEC form 8
2023-05-25 00:00 ET
23andMe reported for 2023 q1
SEC form 6
2023-04-17 16:10 ET
23andMe published news for 2023 q1
SEC form 6
2023-04-14 16:08 ET
23andMe published news for 2023 q1
SEC form 10
2023-02-08 16:11 ET
23andMe reported for 2022 q4
SEC form 6
2023-02-08 16:09 ET
23andMe published news for 2022 q4
SEC form 10
2023-02-08 00:00 ET
23andMe published news for 2022 q4
SEC form 8
2023-02-08 00:00 ET
23andMe reported for 2022 q4
SEC form 6
2023-02-06 16:53 ET
23andMe published news for 2022 q4
SEC form 6
2022-12-09 08:05 ET
23andMe published news for 2022 q3
SEC form 6
2022-11-09 07:30 ET
23andMe published news for 2022 q3
SEC form 10
2022-11-07 16:12 ET
23andMe reported for 2022 q3
SEC form 6
2022-11-07 16:06 ET
23andMe published news for 2022 q3
SEC form 10
2022-11-07 00:00 ET
23andMe reported for 2022 q3
SEC form 8
2022-11-07 00:00 ET
23andMe reported for 2022 q3
SEC form 6
2022-11-04 16:06 ET
23andMe published news for 2022 q3
SEC form 6
2022-10-27 07:32 ET
23andMe published news for 2022 q3
SEC form 6
2022-08-31 19:13 ET
23andMe published news for 2022 q2
SEC form 6
2022-08-30 16:05 ET
23andMe published news for 2022 q2
SEC form 6
2022-08-19 08:02 ET
23andMe published news for 2022 q2
SEC form 6
2022-08-18 16:06 ET
23andMe published news for 2022 q2
SEC form 6
2022-08-09 16:22 ET
23andMe published news for 2022 q2
SEC form 10
2022-08-09 16:19 ET
23andMe reported for 2022 q2
SEC form 10
2022-08-09 00:00 ET
23andMe reported for 2022 q2
SEC form 6
2022-08-08 16:14 ET
23andMe published news for 2022 q2
SEC form 8
2022-08-08 00:00 ET
23andMe reported for 2022 q2
SEC form 6
2022-07-15 08:05 ET
23andMe published news for 2022 q2
SEC form 6
2022-06-13 16:05 ET
23andMe published news for 2022 q1
SEC form 10
2022-05-27 16:03 ET
23andMe reported for 2022 q1
SEC form 10
2022-05-27 00:00 ET
23andMe reported for 2022 q1
SEC form 6
2022-05-26 16:02 ET
23andMe published news for 2022 q1
SEC form 8
2022-05-26 00:00 ET
23andMe reported for 2022 q1
SEC form 6
2022-04-13 16:57 ET
23andMe published news for 2022 q1
SEC form 6
2022-02-23 09:31 ET
23andMe published news for 2021 q4
SEC form 10
2022-02-11 13:45 ET
23andMe published news for 2021 q4
SEC form 10
2022-02-11 00:00 ET
23andMe published news for 2021 q4
SEC form 6
2022-02-10 16:11 ET
23andMe published news for 2021 q4
SEC form 8
2022-02-10 00:00 ET
23andMe published news for 2021 q4
SEC form 6
2022-01-18 08:15 ET
23andMe published news for 2021 q4
SEC form 6
2022-01-10 08:16 ET
23andMe published news for 2021 q4
SEC form 6
2022-01-06 16:05 ET
23andMe published news for 2021 q4
SEC form 6
2021-12-28 16:16 ET
23andMe published news for 2021 q3
SEC form 6
2021-11-22 16:31 ET
23andMe published news for 2021 q3
SEC form 10
2021-11-10 16:21 ET
23andMe published news for 2021 q3
SEC form 6
2021-11-10 16:11 ET
23andMe published news for 2021 q3
SEC form 10
2021-11-10 00:00 ET
23andMe published news for 2021 q3
SEC form 8
2021-11-10 00:00 ET
23andMe published news for 2021 q3
SEC form 6
2021-11-09 16:06 ET
23andMe published news for 2021 q3
SEC form 6
2021-11-02 08:02 ET
23andMe published news for 2021 q3
SEC form 6
2021-10-22 16:05 ET
23andMe published news for 2021 q3
SEC form 6
2021-09-10 07:02 ET
23andMe published news for 2021 q2
SEC form 10
2021-08-13 10:52 ET
23andMe published news for 2021 q2
SEC form 6
2021-08-13 07:13 ET
23andMe published news for 2021 q2
SEC form 10
2021-08-13 00:00 ET
23andMe published news for 2021 q2
SEC form 8
2021-08-13 00:00 ET
23andMe published news for 2021 q2
SEC form 6
2021-07-02 18:25 ET
23andMe published news for 2021 q2
SEC form 6
2021-06-25 17:36 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-25 17:35 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-25 17:27 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-25 17:24 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-25 17:24 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-25 17:22 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-25 17:22 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-25 17:21 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-25 17:20 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-25 17:19 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-25 17:18 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-25 17:16 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-21 08:32 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-21 08:31 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-11 17:28 ET
23andMe published news for 2021 q1
SEC form 6
2021-06-04 17:06 ET
23andMe published news for 2021 q1
SEC form 10
2021-06-03 13:31 ET
23andMe published news for 2021 q1
SEC form 10
2021-06-03 00:00 ET
23andMe published news for 2021 q1
SEC form 6
2021-05-28 17:15 ET
23andMe published news for 2021 q1
SEC form 6
2021-05-26 19:30 ET
23andMe published news for 2021 q1
SEC form 6
2021-05-17 16:14 ET
23andMe published news for 2021 q1
SEC form 6
2021-05-04 17:03 ET
23andMe published news for 2021 q1
SEC form 6
2021-05-03 17:23 ET
23andMe published news for 2021 q1
SEC form 6
2021-04-05 20:37 ET
23andMe published news for 2021 q1
SEC form 6
2021-03-30 17:25 ET
23andMe published news for 2020 q4
SEC form 10
2021-03-24 17:21 ET
23andMe published news for 2020 q4
SEC form 6
2021-02-16 16:19 ET
23andMe published news for 2020 q4
SEC form 6
2021-02-04 08:45 ET
23andMe published news for 2020 q4
SEC form 6
2020-11-20 16:15 ET
23andMe published news for 2020 q3
SEC form 10
2020-11-16 16:01 ET
23andMe published news for 2020 q3
SEC form 6
2020-10-22 16:18 ET
23andMe published news for 2020 q3
SEC form 6
2020-10-13 16:11 ET
23andMe published news for 2020 q3
SEC form 6
2020-10-06 16:31 ET
23andMe published news for 2020 q3
SEC form 6
2020-10-01 21:42 ET
23andMe published news for 2020 q3
SEC form 6
2020-10-01 21:41 ET
23andMe published news for 2020 q3
SEC form 6
2020-10-01 21:40 ET
23andMe published news for 2020 q3
SEC form 6
2020-10-01 21:40 ET
23andMe published news for 2020 q3
SEC form 6
2020-10-01 21:39 ET
23andMe published news for 2020 q3
SEC form 6
2020-10-01 21:39 ET
23andMe published news for 2020 q3